Joseph Moss
Optometrist · Monroe, LANPI 1356506570
Payments from drug & device makers
Across 54 payments — averaging $57.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Oyster Point Pharma, Inc.$263
- Johnson & Johnson Vision Care, Inc.$259
- Optos, Inc.$203
- Shire North American Group Inc$190
- Tarsus Pharmaceuticals, Inc.$171
- plus $783 from 8 others
What the payments were for
- Speaking & faculty fees$2348%
- Food & beverage$2,78489%
- Gifts$191%
- Entertainment$783%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $1,245 |
| Oyster Point Pharma, Inc. | 3 | $263 |
| Johnson & Johnson Vision Care, Inc. | 5 | $259 |
| Optos, Inc. | 2 | $203 |
| Shire North American Group Inc | 2 | $190 |
| Tarsus Pharmaceuticals, Inc. | 4 | $171 |
| Biotissue Holdings Inc. | 1 | $155 |
| AbbVie | 2 | $149 |
| Sun Pharmaceutical Industries Inc. | 2 | $133 |
| Dompe US, Inc. | 1 | $124 |
| Mallinckrodt Hospital Products Inc. | 1 | $103 |
| Apellis Pharmaceuticals, Inc. | 1 | $77 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$251
- DAILIES$234
- Precision 7$131
- OCT OPHTHALMOSCOPE$125
- NFC-700$125
- Oxervate$124
- XIIDRA$124
- CEQUA$117
- Precision7$116
- ACTHAR$103
How this compares
$3,115 in reported general payments places this provider in the 75th percentile of 500 optometrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 161 | $2,791 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $560 |
| Timolol Maleate | 45 | $234 |
| ErythromycinErythromycin Base | 11 | $104 |
| Cephalexin | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Monroe
- Pamela TheriotShreveport$207K
- Joshua DavidsonGonzales$189K
- Jeffrey WilhiteMarrero$86K
- Christopher WrotenHammond$59K
- James LamarNew Orleans$45K
- Stephen LewisShreveport$37K
- John McCallLogansport$32K
- Jason AllemondZachary$26K
- Robert KellyMarrero$26K
- Shane FontenotJennings$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.